Skip to main content
Clinical Trials/NCT07087808
NCT07087808RecruitingNot Applicable

Digital Wellness Nurse - FIT Families: Virtual Family Intervention for Adolescent Obesity

Machine and Human Interaction2 sites in 1 country32 target enrollmentStarted: June 20, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
32
Locations
2
Primary Endpoint
Engagement

Study Overview

Brief Summary

The purpose of the research is to evaluate the digital wellness nurse (DWN) app to find out if it is helpful in delivering the FIT Families intervention. The study is sponsored by the National Institutes of Health (NIH).

Detailed Description

The focus of the DWN for this study, in collaboration with the Medical University of South Carolina (MUSC), is to evaluate its feasibility in delivering key components of FIT Families (HL155793), a multicomponent behavioral intervention designed to treat 12-to-17-year-old African American (AA) adolescents with obesity (AAAO).

The study aims to expand the FIT Families intervention through a digital adaptation that utilizes mobile technology and automation to increase access and adherence. Specifically, the DWN platform will assist AAAOs and their primary caregivers (participants) in understanding, tracking, and completing intervention components; delivering educational content when needed; and collecting information from external sources such as wearables. An analysis of their progression will provide the participants' incentives for adhering to intervention components, for example increasing their participation in self-monitoring (SM) and physical activity (PA). The DWN enables social support (SS) by allowing additional family members or friends to offer messages of encouragement to the participants throughout the treatment. Using our web-based dashboard, community health workers (CHWs) will monitor the progress of their families, meeting with them weekly via video conference within the DWN mobile application.

DWN-FIT will evaluate the feasibility of a digital intervention to expand access and facilitate adherence to family-oriented, evidence-based treatment for AAAOs and their caregivers. Additionally, the realization of DWN-FIT will enable future research and development of evidence-based digital interventions targeting AAAOs. Successful outcomes of the proposed work will provide the evidence needed to support a larger, more comprehensive randomized clinical trial and commercialization of DWN (Phase II).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
12 Years to 17 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adolescents (ages 12-17)
  • •Adolescent BMI ≥ 90th percentile for age and gender
  • •Primary caregiver either overweight (BMI 25.0 to 29.9) or obese (BMI ≥ 30) and willing to participate in treatment
  • •Adolescent residing primarily with the primary caregiver in a rural community (RUCA Codes 4-10)
  • •Both caregiver and adolescent must have (separate) Android or Apple (iOS) smartphone with mobile internet connection
  • •Adolescent and caregiver are English proficient
  • •Supporters must be 18 years of age or older

Exclusion Criteria

  • •Exclusion criteria for youth only:
  • •Obesity secondary to medication use for another medical condition (e.g., steroids, antipsychotics)
  • •Obesity secondary to a chronic condition (e.g., Down syndrome, Prader-Willi syndrome, Cushing's syndrome)
  • •Exclusion criteria that apply to both adolescents and caregivers:
  • •Pregnancy (e.g., caregivers and youth will be asked each week if they expect if they are pregnant)
  • •Mental/emotional disorder (e.g., schizophrenia or other psychosis), suicidal, or homicidal
  • •Serious cognitive impairment (e.g., inability to complete questionnaires)
  • •Medical condition where weight loss is contraindicated
  • •Receiving or planned to receive other obesity treatments (e.g., pharmacologic treatment, bariatric surgery) within the next 6 months

Arms & Interventions

Social Support

Experimental

Participants in the social support arm will receive the same treatment as the control group, including video chatting with health coach, physical activity monitoring, and compensation via contingency management. In addition to these elements, these participants will also assign a social support person to provide them encouragement and accountability.

Intervention: Digital Wellness Nurse - FIT Families (Behavioral)

Control

Active Comparator

The Control arm features the standard digital FIT Families treatment, including video chat with health coach, physical activity, nutrition monitoring, and compensation through contigency management.

Intervention: Digital Wellness Nurse - FIT Families (Behavioral)

Outcomes

Primary Outcomes

Engagement

Time Frame: The PHE survey will be taken via the DWN app at each time point, T0-T3 (wks 0,6, and 12)

We will measure engagement through the delivery of the 9-item Patient Health Engagement (PHE, Graffigna, et al., 2015) survey. The PHE is used to determine the degree to which patients are engaged in their own health and describes the patient's ability to manage their own health. PHE has been validated in other work, but a sample size large enough to meet this threshold is outside the scope of this study. The PHE outcomes gathered here will be used as preliminary data for future studies.

Usability

Time Frame: The SUS will be delivered in week 6 of the intervention.

We will deliver a usability assessment via the System Usability Scale (SUS, Brooke, 1996) assessment focusing on the efficiency and effectiveness of accessing, delivering, and providing support during the intervention. The SUS includes topics such as readability, technology literacy, and interface design. These elements are combined into a semi-quantitative score for system usability.

Engagement

Time Frame: The PHE survey will be taken via the DWN app at each time point, T0-T3 (wks 0,6, and 12)

We will measure engagement through the delivery of the 9-item Patient Health Engagement (PHE, Graffigna, et al., 2015) survey. The PHE is used to determine the degree to which patients are engaged in their own health and describes the patient's ability to manage their own health. PHE has been validated in other work, but a sample size large enough to meet this threshold is outside the scope of this study. The PHE outcomes gathered here will be used as preliminary data for future studies.

Usability

Time Frame: The SUS will be delivered in week 6 of the intervention.

We will deliver a usability assessment via the System Usability Scale (SUS, Brooke, 1996) assessment focusing on the efficiency and effectiveness of accessing, delivering, and providing support during the intervention. The SUS includes topics such as readability, technology literacy, and interface design. These elements are combined into a semi-quantitative score for system usability.

Secondary Outcomes

  • Body Fat Loss(3 months)
  • Body Weight Loss(3 months)
  • Engagement - Time on Task(3 months)
  • Engagement - Physical Activity(3 months)
  • Adherence - Content Completion(3 months)
  • Body Fat Loss(3 months)
  • Body Weight Loss(3 months)
  • Engagement - Time on Task(3 months)
  • Engagement - Physical Activity(3 months)
  • Adherence - Content Completion(3 months)

Investigators

Sponsor
Machine and Human Interaction
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials